| Application no. and date | 03732397.9 (espacenet) (Federated) (European Patent Register), 20030516 | | Patent/reg. no. and date | DK/EP 1507529, 20090422 | | Publication date | 20050223 | | Priority no. and date | US 381547 P, 20020517 | | EP pub. no. and date |
EP 1507529 20050223 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 136334 | | Inventor | WEBB, Randy, Lee, 17 Honeyman Drive
Flemington, NJ 08822, US,
SHETTY, Suraj, Shivappa, 12 Spring Street
Far Hills, NJ 07931, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/19 (2006.01) , A61K 31/196 (2006.01) , A61K 31/4184 (2006.01) , A61K 31/44 (2006.01) , C07D 401/12 (2006.01) | | Title | Kombination indeholdende valsartan, amlodipin og hydrochlorthiazid | | Int. application no. | EP2003005180 | | Int. publication no. | WO2003097045 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
